GPT and granular corneal dystrophy type II: In order to compare hepatic enzymes and coagulation plasma levels in this cohort, 30 to33 patients were selected by their ages and proportional sex ratio to our analysis.Fig. 1 shows the changes in biomarkers of liverfunction (Fig. 1A-B) and coagulation factors (Fig. 1C-D) of ACD patients and healthy subjects.There was a significant increase in the levels of ALT and AST in plasma of ACD patientscompared to healthy subjects.